Method for suppressing the development of graft-versus-host-disease by administering interleukin 6 receptor antibodies
US8529895B2 · kind B2 · utility
14Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2008 |
| Grant date | Sep 10, 2013 |
| Priority date | — |
| Expiry date | May 9, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a novel therapeutic agent for graft-versus-host disease (GVHD).A therapeutic agent for graft-versus-host disease (GVHD), which comprises an interleukin 6 (IL-6) receptor inhibitor as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.